Life sciences leaders discuss the future of commercialization at Indegene Digital Summit | September 21-22, 2023 | Virtual-only

PRINCETON, N.J., Sept. 14, 2023 (GLOBE NEWSWIRE) — Indegene, a digital-first, life sciences commercialization company, announced the fifth edition of Indegene Digital Summit, the annual flagship event for global life sciences leaders, on September 21 – 22, 2023. This exclusive thought leadership virtual event will see thought-provoking strategic discussions pertinent to the commercialization functions of the life sciences value chain.

The summit brings a power-packed lineup of thought leaders from within and beyond the life sciences industry on a single platform to exchange views on the future of commercialization. The leaders will discuss the role of technology paradigms such as Generative AI in transforming traditional commercialization models. They will also address a wide range of topics like launch excellence, technology transformation, precision marketing at scale, and customer experience (CX) transformation.

Click here for the agenda and speaker information: https://digitalsummit.indegene.com/
The event is free from vendors or booths.

Keynote speakers include renowned industry leaders:

  • Peter Schnack, Head of Data, Digital & Technology, SVP, Global Portfolio Division, Takeda
  • Juanjo Francesch, Global CIO Human Health IT & MD of MSD Technology Center, Merck
  • Matt Anderson, Chief Digital Officer and Managing Director, The Carlyle Group, and
  • Sharon Barber-Lui, CFO & SVP, North America, Teva Pharmaceuticals

“The life sciences industry is at an inflection point, with commercial leaders on the lookout for new and different ways to ensure launch success,” said Gaurav Kapoor, Executive Vice President, Indegene, Inc. “This edition of Indegene Digital Summit brings a good mix of business and technology leaders to exchange thoughts on the future of commercialization and AI-driven transformation.”

Sessions to watch out for:

  1. The future of content in the biopharma industry
  2. Generative AI in Life Sciences – Sorting the hype from the hope!
  3. The new world of omnichannel: Embracing emerging channels and disruptive tech in customer engagement
  4. Breaking silos: Aligning HCP and patient engagement for better Rx and patient outcomes
  5. Elevating MLR review: Commercial Ops’, Reviewers’, and Regulators’ insights on emerging trends

Indegene Digital Summit is a #FutureReadyHealthcare initiative, orchestrated by Indegene. Visit https://digitalsummit.indegene.com/ to register for the free, virtual-only, two-day event. For live updates, follow #FutureReadyHealthcare on LinkedIn.

About Indegene

Indegene is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives Indegene’s team and their purpose to enable healthcare organizations be future ready. To learn more, please visit www.indegene.com

For media inquiries, please contact:
Yadunandan K V | yadunandan.kv@indegene.com

Staff

Recent Posts

Danish start-up Kvantify secures EUR 10 million seed round to unlock quantum computing potential, starting with life sciences

The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…

14 mins ago

High-Growth Industries with 25%-30% CAGR Growth Over the Next Five Years

BCC Research Identifies Key Sectors with Substantial Growth Potential, Forecasting Significant Market Expansion Through 2029.…

14 mins ago

Bioz Brings Cutting-Edge AI Citation Widgets to Precision X-Ray, Inc.’s Product Pages

PALO ALTO, CA / ACCESSWIRE / July 3, 2024 / Bioz, Inc., a pioneering AI…

15 mins ago

iZafe Group Receives Confirmed Order of 500 Dosell Units from Ti Medi

STOCKHOLM, SWEDEN / ACCESSWIRE / July 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB…

15 mins ago

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…

3 hours ago

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation…

3 hours ago